Search

Home > OncLive® On Air > 44: Hu Highlights Recent Advances and Approvals in RET-Altered Thyroid Cancer
Podcast: OncLive® On Air
Episode:

44: Hu Highlights Recent Advances and Approvals in RET-Altered Thyroid Cancer
Category: Science & Medicine
Duration: 00:16:01
Publish Date: 2021-03-29 20:00:06
Description: Dr. Hu discusses the importance of testing for RET alterations in thyroid cancer, the FDA approvals of selpercatinib and pralsetinib, and the changing dynamics between medical oncologists and endocrinologists.
Total Play: 0

Some more Podcasts by Audioboom

70+ Episodes
Faith Moveme ..    
100+ Episodes
Videnskab.dk .. 5     1
20+ Episodes
Vidensselska ..    
10+ Episodes
Odd Jobs    
20+ Episodes
Aaron and Ga ..    
100+ Episodes
Ladies of Li .. 4     3
100+ Episodes
Chamber Podc ..    
10+ Episodes
IT'S A GROWN ..